ONWARD MEDICAL N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.4 EUR | -0.37% |
|
+5.88% | +74.19% |
Business Summary
Number of employees: 99
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 49 | 13-12-31 | |
Vincent Delattre
FOU | Founder | - | 13-12-31 |
David Marver
CEO | Chief Executive Officer | - | 19-12-31 |
Khaled Bahi
DFI | Director of Finance/CFO | - | 23-09-30 |
John Murphy
CTO | Chief Tech/Sci/R&D Officer | 57 | 19-12-31 |
Sarah Moore
SAM | Sales & Marketing | - | 23-01-31 |
Erika Ross
LAW | General Counsel | - | 23-01-22 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fredericus Colen
BRD | Director/Board Member | 71 | 16-12-31 |
Jan Öhrström
CHM | Chairman | 67 | 16-04-18 |
Regina Hodits
BRD | Director/Board Member | 53 | 16-04-18 |
| Director/Board Member | 55 | 15-12-31 | |
David Marver
CEO | Chief Executive Officer | - | 19-12-31 |
| Founder | 49 | 13-12-31 | |
Ian Curtis
BRD | Director/Board Member | 56 | 18-12-31 |
Vivian Riefberg
BRD | Director/Board Member | 63 | 22-09-25 |
Kristina Dziekan
BRD | Director/Board Member | - | 22-06-09 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 34,628,832 | 28,071,244 ( 81.06 %) | 0 | 81.06 % |
Company contact information
Sector
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.4
EUR
Average target price
13.85
EUR
Spread / Average Target
+156.48%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +74.19% | 204M | |
| +75.69% | 12.57B | |
| -24.14% | 7.4B | |
| -4.48% | 5.95B | |
| +5.70% | 5.05B | |
| -14.67% | 4.95B | |
| +19.72% | 4.29B | |
| -16.19% | 3.16B | |
| -0.87% | 2.01B | |
| +20.43% | 1.93B |
- Stock Market
- Equities
- ONWD Stock
- Company Onward Medical N.V.
